Idera Pharmaceuticals, Inc. (IDRA) Misses Q2 EPS by 1c

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $38 thousand, versus $29 thousand reported last year.

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Cisco rating cut at HSBC as analyst sees a lack of catalysts
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c